Documents & Downloads

Efmirenpase alfa

Fc-ENPP1 Fusion Protein

Efmirenpase alfa is an Fc-ENPP1 fusion protein, combining a human IgG1 Fc domain with a modified human ENPP1, resulting in a prolonged half-life and improved receptor affinity relative to native ENPP1. This reagent exhibits significant biological activity as an enzyme replacement therapy, making it pertinent for research applications associated with ENPP1 deficiency, including arterial calcification and hypophosphatemic rickets.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2770242-54-9
Applications	Fc-ENPP1 Fusion Protein
Synonyms	INZ-701

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.